Experimental & Molecular Medicine · 2009 · 53 citations · 30 references
Life SciencesCardiologyPharmacologyBiochemical PharmacologyCell SignalingRedox BiochemistryAntioxidant DefenseCardiovascular DiseaseFibrosisOxidative StressReactive Oxygen SpeciesRedox SignalingAntioxidant PropertiesCollagen Type I DepositionFibrotic ChangeMatrix Metalloproteinase ModulationNadph Oxidase ActivityOxidative Stress In FibrosisReactive Oxygen Species GenerationType I Collagen Deposition
Cardiac fibrosis occurs after pathological stimuli to the cardiovascular system. One of the most important factors that contribute to cardiac fibrosis is angiotensin II (AngII). Accumulating studies have suggested that reactive oxygen species (ROS) plays an important role in cardiac fibrosis and sodium tanshinone IIA sulfonate (STS) possesses antioxidant action. We therefore examined whether STS depresses Ang II-induced collagen type I expression in cardiac fibroblasts. In this study, Ang II significantly enhanced collagen type I expression and collagen synthesis. Meanwhile, Ang II depressed matrix metalloproteinase-1 (MMP-1) expression and activity. These responses were attenuated by STS. Furthermore, STS depressed the intracellular generation of ROS, NADPH oxidase activity and subunit p47(phox) expression. In addition, N-acetylcysteine the ROS scavenger, depressed effects of Ang II in a manner similar to STS. In conclusion, the current studies demonstrate that anti-fibrotic effects of STS are mediated by interfering with the modulation of ROS.
30
Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac Fibroblasts
Hiroaki Kawano, Yasuko Kawano, Vaughn A. Starnes et al. · Circulation · 2000 · 313 citations
Medicine, Cardiology, Pharmacology +11
Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
Shokei Kim, Kensuke Ohta, Akinori Hamaguchi et al. · Hypertension · 1995 · 247 citations